Clinical Trials
7
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:4
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (6 trials with phase data)โข Click on a phase to view related trials
Phase 1
4 (66.7%)Phase 2
2 (33.3%)A Longitudinal Observational Cohort Study of NSI-189, With Out-Patients With Major Depressive Disorder
- Conditions
- Major Depressive Disorder
- Interventions
- First Posted Date
- 2016-03-31
- Last Posted Date
- 2016-09-21
- Lead Sponsor
- Neuralstem Inc.
- Target Recruit Count
- 220
- Registration Number
- NCT02724735
Study of NSI-189 for Major Depressive Disorder
Phase 2
- Conditions
- Major Depressive Disorder
- Interventions
- First Posted Date
- 2016-03-01
- Last Posted Date
- 2017-02-24
- Lead Sponsor
- Neuralstem Inc.
- Target Recruit Count
- 220
- Registration Number
- NCT02695472
- Locations
- ๐บ๐ธ
Collaborative Neuroscience Network, LLC, Garden Grove, California, United States
๐บ๐ธSynergy San Diego, National City, California, United States
๐บ๐ธClinical Trials of the Rockies, Denver, Colorado, United States
Safety Study of Human Spinal Cord-derived Neural Stem Cell Transplantation for the Treatment of Chronic SCI
Phase 1
- Conditions
- Spinal Cord Injury (SCI)
- Interventions
- Drug: Human spinal cord stem cells.
- First Posted Date
- 2013-01-21
- Last Posted Date
- 2017-09-11
- Lead Sponsor
- Neuralstem Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT01772810
- Locations
- ๐บ๐ธ
UCSD Medical Center, Division of Neurosurgery, San Diego, California, United States
Dose Escalation and Safety Study of Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis
Phase 2
- Conditions
- Amyotrophic Lateral Sclerosis
- First Posted Date
- 2012-11-21
- Last Posted Date
- 2015-04-20
- Lead Sponsor
- Neuralstem Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT01730716
- Locations
- ๐บ๐ธ
Emory University, Atlanta, Georgia, United States
๐บ๐ธMassachusetts General Hospital, Boston, Massachusetts, United States
๐บ๐ธUniversity of Michigan, Ann Arbor, Michigan, United States
Multiple-Dose Pharmacokinetics (PK), and Pharmacodynamic (PD) Effect of NSI-189 Phosphate in Depression Patient Subjects
Phase 1
Completed
- Conditions
- Depression
- Interventions
- First Posted Date
- 2012-01-30
- Last Posted Date
- 2014-04-02
- Lead Sponsor
- Neuralstem Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT01520649
- Locations
- ๐บ๐ธ
California Clinical Trials, Glendale, California, United States
- Prev
- 1
- 2
- Next
News
No news found